KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Non Operating Income (2016 - 2026)

Johnson & Johnson's Non Operating Income history spans 18 years, with the latest figure at -$294.0 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 104.02% to -$294.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$406.0 million, a 108.07% decrease, with the full-year FY2025 number at $7.2 billion, up 253.58% from a year prior.
  • Non Operating Income hit -$294.0 million in Q1 2026 for Johnson & Johnson, up from -$483.0 million in the prior quarter.
  • Over the last five years, Non Operating Income for JNJ hit a ceiling of $7.3 billion in Q1 2025 and a floor of -$6.9 billion in Q2 2023.
  • Historically, Non Operating Income has averaged -$302.4 million across 5 years, with a median of -$273.0 million in 2022.
  • Biggest five-year swings in Non Operating Income: tumbled 6903.92% in 2023 and later skyrocketed 404.53% in 2025.
  • Tracing JNJ's Non Operating Income over 5 years: stood at -$226.0 million in 2022, then soared by 286.28% to $421.0 million in 2023, then crashed by 61.76% to $161.0 million in 2024, then plummeted by 400.0% to -$483.0 million in 2025, then soared by 39.13% to -$294.0 million in 2026.
  • Business Quant data shows Non Operating Income for JNJ at -$294.0 million in Q1 2026, -$483.0 million in Q4 2025, and $478.0 million in Q3 2025.